Member Profiles
A chair-stand time of greater than 15 seconds is associated with an increased risk of death and hospitalization in cirrhosis. Can Liver J. 2023 Oct; 6(3):358-362. Nguyen VV, Wang S, Whitlock R, Xu C, Taneja S, Singh S, Abraldes JG, Burak K, Bailey RJ, Grab JD, Lai JC, Tandon P. PMID: 38020188; PMCID: PMC10652985.
Frailty is associated with increased risk of cirrhosis disease progression and death. Hepatology. 2022 03; 75(3):600-609. Wang S, Whitlock R, Xu C, Taneja S, Singh S, Abraldes JG, Burak KW, Bailey RJ, Lai JC, Tandon P. PMID: 34528267.
The relationship between frailty and cirrhosis etiology: From the Functional Assessment in Liver Transplantation (FrAILT) Study. Liver Int. 2021 10; 41(10):2467-2473. Xu CQ, Mohamad Y, Kappus MR, Boyarsky B, Ganger DR, Volk ML, Rahimi RS, Duarte-Rojo A, McAdams-DeMarco M, Segev DL, Ladner DP, Verna EC, Grab J, Tincopa M, Dunn MA, Lai JC. PMID: 34219362; PMCID: PMC8522207.
The Updated US Preventive Services Task Force Hepatitis B Screening Recommendations-Staying Committed. JAMA Intern Med. 2021 03 01; 181(3):310-312. Xu CQ, Zhou K, Brandman D. PMID: 33320176.
Adherence to pregnancy hepatitis B care guidelines in women and infants in the United States and evaluation of two interventions to improve care: A multicentre hospital-based study. J Viral Hepat. 2021 04; 28(4):582-591. Kushner T, Kaplowitz E, Mei R, Xu C, Acker A, Rosenbluth E, Oredein I, Sarkar M, Terrault N, Bansal M, Forde KA. PMID: 33372359.
Selected Publications
A chair-stand time of greater than 15 seconds is associated with an increased risk of death and hospitalization in cirrhosis. Can Liver J. 2023 Oct; 6(3):358-362. Nguyen VV, Wang S, Whitlock R, Xu C, Taneja S, Singh S, Abraldes JG, Burak K, Bailey RJ, Grab JD, Lai JC, Tandon P. PMID: 38020188; PMCID: PMC10652985.
Frailty is associated with increased risk of cirrhosis disease progression and death. Hepatology. 2022 03; 75(3):600-609. Wang S, Whitlock R, Xu C, Taneja S, Singh S, Abraldes JG, Burak KW, Bailey RJ, Lai JC, Tandon P. PMID: 34528267.
The relationship between frailty and cirrhosis etiology: From the Functional Assessment in Liver Transplantation (FrAILT) Study. Liver Int. 2021 10; 41(10):2467-2473. Xu CQ, Mohamad Y, Kappus MR, Boyarsky B, Ganger DR, Volk ML, Rahimi RS, Duarte-Rojo A, McAdams-DeMarco M, Segev DL, Ladner DP, Verna EC, Grab J, Tincopa M, Dunn MA, Lai JC. PMID: 34219362; PMCID: PMC8522207.
The Updated US Preventive Services Task Force Hepatitis B Screening Recommendations-Staying Committed. JAMA Intern Med. 2021 03 01; 181(3):310-312. Xu CQ, Zhou K, Brandman D. PMID: 33320176.
Adherence to pregnancy hepatitis B care guidelines in women and infants in the United States and evaluation of two interventions to improve care: A multicentre hospital-based study. J Viral Hepat. 2021 04; 28(4):582-591. Kushner T, Kaplowitz E, Mei R, Xu C, Acker A, Rosenbluth E, Oredein I, Sarkar M, Terrault N, Bansal M, Forde KA. PMID: 33372359.
Academy of Educators Educational Grant Recipient (AGA, 2023)
Selected Accolades
Academy of Educators Educational Grant Recipient (AGA, 2023)
Faculty Member, Academy of Endoscopy
Other Positions and Professional Services
Faculty Member, Academy of Endoscopy
Simulation-based mastery learning
Medical education
Research Interests
Simulation-based mastery learning
Medical education
Attending physician, Palo Alto Medical Foundation in Palo Alto
Job Title/Position and Hospital/Academic Institution
Attending physician, Palo Alto Medical Foundation in Palo Alto
MD
Academic and Professional Qualifications
MD
Chelsea Xu, MD is an attending gastroenterologist at Palo Alto Medical Foundation in Palo Alto. She obtained her medical degree from the University of California, San Francisco (UCSF). She subsequently completed her residency in internal medicine and fellowship in Gastroenterology and Hepatology also at UCSF. She has a particular interest in medical education and was awarded the Academy of Educators Educational Grant from the AGA in 2023. At UCSF, we conducted a prospective, randomized control trial of a simulation-based mastering learning intervention, comparing the acquisition and retention of over-the-scope clipping skills to traditional training methods. Our work was selected for an oral presentation at Digestive Diseases Week (DDW) at Washington, DC in May 2024.
Short Bio
Chelsea Xu, MD is an attending gastroenterologist at Palo Alto Medical Foundation in Palo Alto. She obtained her medical degree from the University of California, San Francisco (UCSF). She subsequently completed her residency in internal medicine and fellowship in Gastroenterology and Hepatology also at UCSF. She has a particular interest in medical education and was awarded the Academy of Educators Educational Grant from the AGA in 2023. At UCSF, we conducted a prospective, randomized control trial of a simulation-based mastering learning intervention, comparing the acquisition and retention of over-the-scope clipping skills to traditional training methods. Our work was selected for an oral presentation at Digestive Diseases Week (DDW) at Washington, DC in May 2024.
USA
Chelsea Xu, MD
Contact